Inspire Medical Systems, Inc. (NYSE:INSP) CFO Richard Buchholz Sells 15,000 Shares

Inspire Medical Systems, Inc. (NYSE:INSP) CFO Richard Buchholz sold 15,000 shares of Inspire Medical Systems stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $230.03, for a total transaction of $3,450,450.00. Following the completion of the transaction, the chief financial officer now directly owns 28,271 shares of the company’s stock, valued at approximately $6,503,178.13. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Inspire Medical Systems Trading Down 1.0 %

Shares of NYSE:INSP opened at $241.12 on Friday. Inspire Medical Systems, Inc. has a twelve month low of $123.27 and a twelve month high of $330.00. The company has a 50-day moving average price of $202.84 and a two-hundred day moving average price of $183.76.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.53. Inspire Medical Systems had a negative net margin of 3.39% and a negative return on equity of 3.93%. The firm had revenue of $192.51 million for the quarter, compared to the consensus estimate of $186.75 million. During the same period last year, the firm posted $0.10 earnings per share. The business’s revenue was up 39.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post -0.35 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on INSP. Stifel Nicolaus restated a “hold” rating and set a $210.00 target price on shares of Inspire Medical Systems in a research note on Tuesday, January 2nd. Morgan Stanley began coverage on shares of Inspire Medical Systems in a research note on Tuesday, March 19th. They set an “overweight” rating and a $250.00 target price for the company. Jefferies Financial Group began coverage on shares of Inspire Medical Systems in a research note on Friday, January 19th. They set a “buy” rating and a $245.00 target price for the company. Mizuho restated a “buy” rating and set a $250.00 target price on shares of Inspire Medical Systems in a research note on Wednesday, March 27th. Finally, Truist Financial restated a “buy” rating and set a $280.00 target price on shares of Inspire Medical Systems in a research note on Wednesday, March 20th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $271.29.

Hedge Funds Weigh In On Inspire Medical Systems

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. FMR LLC raised its position in shares of Inspire Medical Systems by 130.1% in the 3rd quarter. FMR LLC now owns 2,471,464 shares of the company’s stock worth $490,437,000 after purchasing an additional 1,397,510 shares during the last quarter. Baillie Gifford & Co. raised its position in Inspire Medical Systems by 6,846.9% in the 4th quarter. Baillie Gifford & Co. now owns 1,229,879 shares of the company’s stock worth $250,194,000 after buying an additional 1,212,175 shares during the last quarter. Wellington Management Group LLP raised its position in Inspire Medical Systems by 46.4% in the 4th quarter. Wellington Management Group LLP now owns 1,430,266 shares of the company’s stock worth $290,959,000 after buying an additional 453,294 shares during the last quarter. Frontier Capital Management Co. LLC grew its stake in shares of Inspire Medical Systems by 105.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 742,046 shares of the company’s stock valued at $150,954,000 after purchasing an additional 380,362 shares during the period. Finally, Jennison Associates LLC grew its stake in shares of Inspire Medical Systems by 648.2% during the 4th quarter. Jennison Associates LLC now owns 304,886 shares of the company’s stock valued at $62,023,000 after purchasing an additional 264,139 shares during the period. Hedge funds and other institutional investors own 94.91% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.